These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. A randomized trial of cisplatin, vinblastine, and bleomycin versus vinblastine, cisplatin, and etoposide in the treatment of advanced germ cell tumors of the testis: a Southwest Oncology Group study. Wozniak AJ; Samson MK; Shah NT; Crawford ED; Ford CD; Altman SJ; Stephens RL; Natale RB; Bouroncle BA; Blumenstein BA J Clin Oncol; 1991 Jan; 9(1):70-6. PubMed ID: 1702148 [TBL] [Abstract][Full Text] [Related]
4. Modified cisplatin, etoposide (or vinblastine) and ifosfamide salvage therapy for male germ-cell tumors. Long-term results. Pizzocaro G; Salvioni R; Piva L; Faustini M; Nicolai N; Gianni L Ann Oncol; 1992 Mar; 3(3):211-6. PubMed ID: 1316779 [TBL] [Abstract][Full Text] [Related]
5. Randomized trial comparing bleomycin/etoposide/cisplatin with alternating cisplatin/cyclophosphamide/doxorubicin and vinblastine/bleomycin regimens of chemotherapy for patients with intermediate- and poor-risk metastatic nonseminomatous germ cell tumors: Genito-Urinary Group of the French Federation of Cancer Centers Trial T93MP. Culine S; Kramar A; Théodore C; Geoffrois L; Chevreau C; Biron P; Nguyen BB; Héron JF; Kerbrat P; Caty A; Delva R; Fargeot P; Fizazi K; Bouzy J; Droz JP; J Clin Oncol; 2008 Jan; 26(3):421-7. PubMed ID: 18202419 [TBL] [Abstract][Full Text] [Related]
6. A prospective study of cisplatin-based combination chemotherapy in advanced germ cell malignancy: role of maintenance and long-term follow-up. Levi JA; Thomson D; Sandeman T; Tattersall M; Raghavan D; Byrne M; Gill G; Harvey V; Burns I; Snyder R J Clin Oncol; 1988 Jul; 6(7):1154-60. PubMed ID: 2455778 [TBL] [Abstract][Full Text] [Related]
7. Therapy of extragonadal germ-cell tumors. Daugaard G; Rørth M; Hansen HH Eur J Cancer Clin Oncol; 1983 Jul; 19(7):895-9. PubMed ID: 6192996 [TBL] [Abstract][Full Text] [Related]
8. Treatment of testicular cancer: a new and improved model. Einhorn LH J Clin Oncol; 1990 Nov; 8(11):1777-81. PubMed ID: 1700077 [TBL] [Abstract][Full Text] [Related]
9. The importance of bleomycin in combination chemotherapy for good-prognosis germ cell carcinoma. Australasian Germ Cell Trial Group. Levi JA; Raghavan D; Harvey V; Thompson D; Sandeman T; Gill G; Stuart-Harris R; Snyder R; Byrne M; Kerestes Z J Clin Oncol; 1993 Jul; 11(7):1300-5. PubMed ID: 7686216 [TBL] [Abstract][Full Text] [Related]
10. Sequential trials of cisplatin, vinblastine, and bleomycin and etoposide and cisplatin in disseminated nonseminomatous germ cell tumors of the testis with a good prognosis at a single institution. Germá JR; Sagarra AF; Izquierdo MA; Seguí MA Cancer; 1993 Feb; 71(3):796-803. PubMed ID: 7679314 [TBL] [Abstract][Full Text] [Related]
11. Prognostic analysis of Japanese men with metastatic germ cell tumors showing favorable response to bleomycin, etoposide and cisplatin as first-line chemotherapy. Kumano M; Miyake H; Hara I; Muramaki M; Takenaka A; Fujisawa M Hinyokika Kiyo; 2007 Dec; 53(12):851-6. PubMed ID: 18203521 [TBL] [Abstract][Full Text] [Related]